NCT03998319: A Study of Low-dose Intracoronary Thrombolytic Therapy in STEMI (Heart Attack) Patients.
- State
- Under way
- Phase
- Phase 3
- People
- 445 planned
- Started
- 14 Oct 2021
- Primary completion
- 31 Dec 2024
- Arms
- Tenecteplase (1/3 systemic weight based dose)
- Results
- None posted
- 26 Jun 2019: Trial registered
- 14 Oct 2021: Trial started